Observational studyScientific reports2020

Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degeneration.

Andreas Ebneter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.